Literature DB >> 10369864

The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.

B Vaidya1, H Imrie, P Perros, E T Young, W F Kelly, D Carr, D M Large, A D Toft, M I McCarthy, P Kendall-Taylor, S H Pearce.   

Abstract

Graves' disease (GD) is an autoimmune thyroid disorder that is inherited as a complex trait. We have genotyped 77 affected sib-pairs with autoimmune thyroid disease for eight polymorphic markers spanning the cytotoxic T lymphocyte antigen-4 ( CTLA-4 ) region of chromosome 2q31-q33, and for five markers spanning the major histocompatibility complex ( MHC ) region of chromosome 6p21. Non-parametric analysis showed linkage of GD to the CTLA-4 region with a peak non-parametric linkage (NPL) score of 3.43 ( P = 0.0004) at the marker D2S117. The proportion of affected full-sibs sharing zero alleles (z0) reached a minimum of 0.113 close to D2S117, giving a locus-specific lambdas for this region of 2.2. Families with brother-sister sib-pairs showed a peak NPL of 3.46 ( P = 0.0003, lambdas > 10) at D2S117, compared with 2.00 ( P = 0.02, lambdas = 1.9) in the families with only affected females, suggesting a stronger influence in families with affected males. Association between GD and the G allele of the Thr17Ala polymorphism within the CTLA-4 gene ( CTLA4A/G ) was observed using unaffected sib controls ( P = 0.005). Lesser evidence for linkage was found at the MHC locus, with a peak NPL score of 1.95 ( P = 0.026), between the markers D6S273 and TNFalpha. We demonstrate that the CTLA-4 locus (lambdas = 2.2) and the MHC locus (lambdas = 1.6) together confer approximately 50% of the inherited susceptibility to GD disease in our population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369864     DOI: 10.1093/hmg/8.7.1195

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease.

Authors:  S H Pearce; B Vaidya; H Imrie; P Perros; W F Kelly; A D Toft; M I McCarthy; E T Young; P Kendall-Taylor
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.

Authors:  Xiaoming Yin; Rauf Latif; Rebecca Bahn; Terry F Davies
Journal:  Thyroid       Date:  2012-06-04       Impact factor: 6.568

3.  Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients.

Authors:  Takashi Akamizu; Hitomi Hiratani; Satoshi Ikegami; Stephen S Rich; Donald W Bowden
Journal:  J Hum Genet       Date:  2003-04-09       Impact factor: 3.172

4.  CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy.

Authors:  Steven Young-Min; Bijay Vaidya
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

5.  Diagnostic tools in Rhinology EAACI position paper.

Authors:  Glenis Scadding; Peter Hellings; Isam Alobid; Claus Bachert; Wytske Fokkens; Roy Gerth van Wijk; Philippe Gevaert; Josep Guilemany; Livije Kalogjera; Valerie Lund; Joaquim Mullol; Giovanni Passalacqua; Elina Toskala; Cornelius van Drunen
Journal:  Clin Transl Allergy       Date:  2011-06-10       Impact factor: 5.871

6.  Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease.

Authors:  W Zhu; N Liu; Y Zhao; H Jia; B Cui; G Ning
Journal:  J Endocrinol Invest       Date:  2010-03-22       Impact factor: 4.256

7.  Association of the TGrI29 microsatellite in thyroglobulin gene with autoimmune thyroiditis in a Argentinian population: a case-control study.

Authors:  Viviana Varela; Leonardo Rizzo; Sabina Domené; Oscar D Bruno; Mariana L Tellechea; Carina M Rivolta; Héctor M Targovnik
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

8.  Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families.

Authors:  Yaron Tomer; Yoshiyuki Ban; Erlinda Concepcion; Giuseppe Barbesino; Ronald Villanueva; David A Greenberg; Terry F Davies
Journal:  Am J Hum Genet       Date:  2003-09-12       Impact factor: 11.025

Review 9.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

10.  Association of CTLA4 gene polymorphism in Iranian patients with ankylosing spondylitis.

Authors:  Esfandiar Azizi; Ahmad Massoud; Ali Akbar Amirzargar; Mahdi Mahmoudi; Narjes Soleimanifar; Nima Rezaei; Ahmad Reza Jamshidi; Behrouz Nikbin; Mohammad Hossein Nicknam
Journal:  J Clin Immunol       Date:  2009-12-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.